Nitto Denko Avecia Revenue and Competitors
Estimated Revenue & Valuation
- Nitto Denko Avecia's estimated annual revenue is currently $115.5M per year.
- Nitto Denko Avecia's estimated revenue per employee is $155,000
Employee Data
- Nitto Denko Avecia has 745 Employees.
- Nitto Denko Avecia grew their employee count by -1% last year.
Nitto Denko Avecia's People
| Name | Title | Email/Phone |
|---|---|---|
1 | VP Business Development | Reveal Email/Phone |
2 | SVP, Regulatory and Quality | Reveal Email/Phone |
3 | Head Strategic Sourcing | Reveal Email/Phone |
4 | SVP Human Resources; Board Directors | Reveal Email/Phone |
5 | Director Quality | Reveal Email/Phone |
6 | Senior Director Process Development | Reveal Email/Phone |
7 | Associate Director Supply Chain | Reveal Email/Phone |
8 | Director, Analytical Development | Reveal Email/Phone |
9 | Director Business Development | Reveal Email/Phone |
10 | Associate Director Analytical Development and QC | Reveal Email/Phone |
Nitto Denko Avecia Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $5.2M | 67 | -45% | $107.3M | N/A |
#2 | $0.3M | 2 | 0% | N/A | N/A |
#3 | $5.1M | 33 | 6% | N/A | N/A |
#4 | $11.9M | 77 | -37% | $312.8M | N/A |
#5 | $0.9M | 6 | 0% | N/A | N/A |
#6 | $235M | 300 | -5% | $340.9M | N/A |
#7 | $45.9M | 237 | -7% | $7.6M | N/A |
#8 | $3.9M | 50 | 35% | N/A | N/A |
#9 | $5.4M | 35 | 3% | N/A | N/A |
#10 | $1.6M | 10 | 0% | N/A | N/A |
What Is Nitto Denko Avecia?
Nitto Denko Avecia is the largest oligonucleotide manufacturer in the world and continues to play an integral role in advancing the oligo therapeutic market. With over 20 years of experience and over 1,000 sequences manufactured, we fulfill our client's needs for pre-clinical, clinical, and launched products. With production capacity in FDA- audited facilities near Boston, MA, and Cincinnati, OH, we produce a novel class of active pharmaceutical ingredients (APIs) -- oligonucleotides -- used by pharmaceutical and biotechnology companies to develop drug treatments for a variety of health indications. In addition to our pre-clinical and CGMP oligo manufacturing capability, we leverage our wealth of expertise to offer a portfolio of services that includes Analytical Development, Process Development, and Quality Control testing.
keywords:Biotechnology,Cleantech,Finance,Healthcare,Pharmaceuticals,Wind Power
N/A
Total Funding
745
Number of Employees
$115.5M
Revenue (est)
-1%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Nitto Denko Avecia News
... Thermo Fisher Scientific, Bioautomation, Agilent Technologies, Eurogentec, GE Healthcare, LGC Biosearch Technologies, Nitto Denko Avecia.
... Technologies Inc., Eurogentec S.A., General Electric Company, Thermo Fisher Scientific Biosearch Technologies, Nitto Denko Avecia Inc.
... Sigma-aldrich, Eurofins Genomics, L.G.C Biosearch Technologies, Eurogentec S.A, Nitto Denko Avecia Inc, GenScript, BBI Life Sciences, GeneDesign.
Other Companies in Milford
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $224.8M | 892 | 11% | N/A |
#2 | $161.4M | 961 | 21% | N/A |
#3 | $161.4M | 961 | 21% | N/A |
#4 | $151M | 974 | 6% | N/A |
#5 | $497.2M | 1006 | 5% | N/A |